Proximal shift of colorectal cancer along with aging

Clinical Colorectal Cancer

Volumn 13, Issue 4, 2014, Pages 213-218

  Iida, Yuuki ^a   Kawai, Kazushige ^a   Tsuno, Nelson H ^a   Ishihara, Soichiro ^a   Yamaguchi, Hironori ^a   Sunami, Eiji ^a   Kitayama, Joji ^a   Watanabe, Toshiaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenoma; Elderly; Gender; Proximal colon

Indexed keywords

AGED; AGING; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; DISTANT METASTASIS; GROUPS BY AGE; HISTOLOGY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SEX DIFFERENCE; ADENOMA; ADULT; AGE; COLLOID CARCINOMA; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; FOLLOW UP; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR; SECONDARY; VERY ELDERLY;

ADENOCARCINOMA, MUCINOUS; ADENOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS;

EID: 84922518394     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2014.06.005     Document Type: Article

References (25)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Ito Y, Nakayama T, Miyashiro I, et al. Trends in 'cure' fraction from colorectal cancer by age and tumour stage between 1975 and 2000, using population-based data, Osaka, Japan. Jpn J Clin Oncol 2012; 42: 974-83.
3. Shah AB, Sarfati D, Blakely T, et al. Trends in colorectal cancer incidence rates in New Zealand, 1981-2004. ANZ J Surg 2012; 82: 258-64.
4. Singh H, Demers AA, Xue L, et al. Time trends in colon cancer incidence and distribution and lower gastrointestinal endoscopy utilization in Manitoba. Am J Gastroenterol 2008; 103: 1249-56.
5. Arai T, Takubo K. Clinicopathological and molecular characteristics of gastric and colorectal carcinomas in the elderly. Pathol Int 2007; 57: 303-14.
6. Arai T, Takubo K, Sawabe M, Esaki Y. Pathologic characteristics of colorectal cancer in the elderly: A retrospective study of 947 surgical cases. J Clin Gastroenterol 2000; 31: 67-72.
7. Okamoto M, Shiratori Y, Yamaji Y, et al. Relationship between age and site of colorectal cancer based on colonoscopy findings. Gastrointest Endosc 2002; 55: 548-51.
8. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM classification of malignant tumours. Chichester, West Sussex, England: Wiley-Blackwell; 2010.
9. Gervaz P, Bucher P, Morel P. Two colons-two cancers: Paradigm shift and clinical implications. J Surg Oncol 2004; 88: 261-6.
10. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 2010; 138: 2088-100.
11. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
12. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138: 2073-87, e2073.
13. Samowitz WS, Curtin K, Ma KN, et al. Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001; 10: 917-23.
14. Kakar S, Burgart LJ, Thibodeau SN, et al. Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age. Cancer 2003; 97: 1421-7.
15. Barnes EL, Long MD. Colorectal cancer in women: Hormone replacement therapy and chemoprevention. Climacteric 2012; 15: 250-5.
16. Newcomb PA, Pocobelli G, Chia V. Why hormones protect against large bowel cancer: Old ideas, new evidence. Adv Exp Med Biol 2008; 617: 259-69.
17. Delellis Henderson K, Duan L, Sullivan-Halley J, et al. Menopausal hormone therapy use and risk of invasive colon cancer: The California Teachers Study. Am J Epidemiol 2010; 171: 415-25.
18. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
19. Papaxoinis K, Triantafyllou K, Sasco AJ, et al. Subsite-specific differences of estrogen receptor beta expression in the normal colonic epithelium: Implications for carcinogenesis and colorectal cancer epidemiology. Eur J Gastroenterol Hepatol 2010; 22: 614-9.
20. Debruyne PR, Bruyneel EA, Li X, et al. The role of bile acids in carcinogenesis. Mutat Res 2001; 480-481: 359-69.
21. McMichael AJ, Potter JD. Host factors in carcinogenesis: Certain bile-Acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985; 75: 185-91.
22. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis. J Natl Cancer Inst 1980; 65: 1201-7.
23. Lynn J, Williams L, O'Brien J, et al. Effects of estrogen upon bile: Implications with respect to gallstone formation. Ann Surg 1973; 178: 514-24.
24. McCashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumors. Am J Gastroenterol 2001; 96: 882-6.
25. Brenner H, Hoffmeister M, Stegmaier C, et al. Risk of progression of advanced adenomas to colorectal cancer by age and sex: Estimates based on 840,149 screening colonoscopies. Gut 2007; 56: 1585-9.